Table 2. Immunological Recovery:... | American Society of Hematology

Table 2.

Immunological Recovery: Analysis of Lymphocyte Subsets at Approximately One Year After Allo-BMT

Individual	Lymphocytes^* (×10³/μL)	% CD3^†	% CD4	% CD8	% CD16/56	% CD20
Patient 1 pre-BMT	1.1	65	12	50	29	4
Patient 1 post-BMT	1.3	45	10	29	12	24
Patient 2 pre-BMT	2.8	50	34	13	6	39
Patient 2 post-BMT	6.2	57	20	37	10	26
Reference value^‡
1-2 yr	3.6 (2.9-5.1)	63 (52-74)	41 (27-52)	21 (14-28)	8 (4-15)	27 (15-39)
3-4 yr	3.7 (2.3-5.4)	62 (45-76)	39 (27-47)	18 (10-29)	12 (7-17)	20 (13-39)
Donor 1	2.1	77	37	25	16	10
Donor 2	3.5	65	30	23	14	17
Reference value
5-9 yr	2.6 (1.7-3.5)	72 (51-80)	42 (28-54)	24 (17-32)	8 (5-16)	14 (9-22)
10-14 yr	2.4 (1.6-3.1)	68 (49-83)	39 (32-52)	21 (13-31)	13 (5-23)	15 (9-28)

Individual	Lymphocytes^* (×10³/μL)	% CD3^†	% CD4	% CD8	% CD16/56	% CD20
Patient 1 pre-BMT	1.1	65	12	50	29	4
Patient 1 post-BMT	1.3	45	10	29	12	24
Patient 2 pre-BMT	2.8	50	34	13	6	39
Patient 2 post-BMT	6.2	57	20	37	10	26
Reference value^‡
1-2 yr	3.6 (2.9-5.1)	63 (52-74)	41 (27-52)	21 (14-28)	8 (4-15)	27 (15-39)
3-4 yr	3.7 (2.3-5.4)	62 (45-76)	39 (27-47)	18 (10-29)	12 (7-17)	20 (13-39)
Donor 1	2.1	77	37	25	16	10
Donor 2	3.5	65	30	23	14	17
Reference value
5-9 yr	2.6 (1.7-3.5)	72 (51-80)	42 (28-54)	24 (17-32)	8 (5-16)	14 (9-22)
10-14 yr	2.4 (1.6-3.1)	68 (49-83)	39 (32-52)	21 (13-31)	13 (5-23)	15 (9-28)

Absolute lymphocyte numbers are given: value × 10³cells/μL.

The percentages were determined after staining with appropriate MoAbs and analysis on a FACSscan.

Age-matched reference values39 40 for patients/donors are given as median with ranges from 5th to 95th percentiles in parentheses.